Correction: Comparative efficacy and safety of seven Chinese patent medicines combined with SSRIs for depressive disorder: a systematic review and network meta-analysis - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Erratum: A Systematic Review and Network Meta-Analysis of the Efficacy and Safety of Seven Chinese Patent Medicines in Combination with SSRIs for Treating Depressive Disorders

  • By

  • Hongye Geng

  • Lixuan Li

  • Chengyuan Lu

  • Shuling Wang

  • September 4, 2026

Share

Clinical Report: Erratum on Efficacy and Safety of Chinese Patent Medicines

Background

The use of Chinese patent medicines in conjunction with SSRIs for depressive disorders is a topic of interest. Accurate data presentation is crucial for clinicians to interpret the efficacy and safety of these combinations.

Data Highlights

InterventionMean Differences (MD)95% Confidence Interval (CI)
SSRIs Monotherapy--
CPM + SSRIsSpecific MD valuesSpecific CI values

Key Findings

  • The original Table 1 contained errors in displaying the comparator group and mean differences.
  • The corrected table enhances readability and supports accurate interpretation of the network meta-analysis.
  • The numerical values in the corrected table remain unchanged from the original analysis.
  • This correction does not alter the study’s findings or conclusions.
  • SSRIs monotherapy serves as the common reference for comparisons in the corrected table.

Clinical Implications

Clinicians should refer to the corrected data for accurate interpretation of the efficacy of Chinese patent medicines combined with SSRIs.

Conclusion

The erratum clarifies previously published data without changing the overall conclusions of the study.

Related Resources & Content

  1. Geng H, Li L, Lu C, Wang S, Front. Psychiatry, 2026 -- A Systematic Review and Network Meta-Analysis of the Efficacy and Safety of Seven Chinese Patent Medicines in Combination with SSRIs for Treating Depressive Disorders
  2. Frontiers in Cardiovascular Medicine — Comparative efficacy and safety of oral Chinese patent medicines combined with conventional therapy for coronary heart disease complicated by diabetes: a systematic review and network meta-analysis
  3. Frontiers in Psychiatry — Association between changes in estradiol, serotonin, and BDNF and antidepressant response in perimenopausal depression: a retrospective cohort study comparing integrated TCM-acupuncture with SSRIs
  4. Frontiers in Cardiovascular Medicine — The effectiveness and safety of oral Chinese patent medicines in treating myocardial infarction complicated with heart failure: a network meta-analysis of 12 interventions
  5. Frontiers in Psychiatry — Retraction: Metoprolol, N-Acetylcysteine, and Escitalopram Prevents Chronic Unpredictable Mild Stress-Induced Depression by Inhibition of Endoplasmic Reticulum Stress
  6. Overview | Depression in adults: treatment and management | Guidance | NICE
  7. Frontiers | Comparative efficacy and safety of seven Chinese patent medicines combined with SSRIs for depressive disorder: a systematic review and network meta-analysis
  8. Clinical evidence on integrated Chinese-Western medicine for depressive disorder - PMC

Original Source(s)

Correction: Comparative efficacy and safety of seven Chinese patent medicines combined with SSRIs for depressive disorder: a systematic review and network meta-analysis

  • by Hongye Geng, Lixuan Li, Chengyuan Lu, Shuling Wang

  • September 4, 2026

Related Content

Can Machine Learning Models Tell Us What Treatment Works for Whom?

Gender differences in the effects of economic inequality on mental conditions: a multivariate meta-analysis of Gini index and relative income position in high-income OECD countries

Nocturnal pain in elbow disorders may predict sleep quality

Prospective multicenter study found poorer sleep quality was associated with greater pain and functional disability across common elbow conditions.